Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-87,881
Closed -$153K 3281
2025
Q1
$153K Buy
87,881
+36,538
+71% +$78.1K ﹤0.01% 3165
2024
Q4
$138K Sell
51,343
-26,663
-34% -$83.8K ﹤0.01% 3260
2024
Q3
$179K Buy
78,006
+28,772
+58% +$80.6K ﹤0.01% 3244
2024
Q2
$148K Buy
+49,234
New +$188K ﹤0.01% 3270
2023
Q2
Sell
-107,072
Closed -$248K 3209
2023
Q1
$248K Sell
107,072
-17,349
-14% -$64.6K ﹤0.01% 2949
2022
Q4
$493K Sell
124,421
-5,770
-4% -$32.8K ﹤0.01% 2887
2022
Q3
$797K Sell
130,191
-3,469
-3% -$26.4K ﹤0.01% 2838
2022
Q2
$657K Buy
133,660
+51,179
+62% +$447K ﹤0.01% 2949
2022
Q1
$877K Buy
82,481
+966
+1% +$10.6K ﹤0.01% 2855
2021
Q4
$1.14M Sell
81,515
-9,832
-11% -$174K ﹤0.01% 2815
2021
Q3
$1.34M Buy
91,347
+4,834
+6% +$53.4K ﹤0.01% 2858
2021
Q2
$966K Buy
+86,513
New +$1.36M ﹤0.01% 3019

Other funds holding AMTX

Nuveen's AMTX Position: Q2 2025 in Review

Nuveen sold out of Aemetis (AMTX) in Q2 2025, closing a stake of 87,881 shares — an estimated $153K sold.

Nuveen first reported a position in AMTX in Q2 2021 and held it in 12 quarters. The position peaked at $1.34M in Q3 2021. 71 funds tracked by Wall St. Rank hold AMTX as of Q2 2025.

  • Nuveen reported no remaining Aemetis position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 87,881 Aemetis shares in Q2 2025, an estimated $153K.
  • Nuveen first reported a position in Aemetis in Q2 2021 and held it in 12 quarters.
  • Nuveen's Aemetis position peaked at $1.34M in Q3 2021.
  • 71 funds tracked by Wall St. Rank held Aemetis as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.